Long-lasting nerve block could change pain management

Apr 14, 2009 by Rob Graham
Pink perineurial tissue reacts to multilammellar liposomes containing local anesthetics (the purple dots, shown magnified in the inset). Courtesy Kohane Lab/Children's Hospital Boston

(PhysOrg.com) -- Harvard researchers at Children’s Hospital Boston have developed a slow-release anesthetic drug-delivery system that could potentially revolutionize treatment of pain during and after surgery, and may also have a large impact on chronic pain management.

In work funded by the National Institutes of Health (NIH), they used specially designed fat-based particles called liposomes to package saxitoxin, a potent anesthetic, and produced long-lasting local anesthesia in rats without apparent toxicity to or muscle cells.

The research will be published online during the week of April 13-17 by the .

“The idea was to have a single injection that could produce a nerve block lasting days, weeks, maybe even months,” explains Daniel Kohane of the Division of Critical Care Medicine in the Department of Anesthesiology at Children’s, the report’s senior author, and associate professor of anesthesia at Harvard Medical School. “It would be useful for conditions like where, rather than use narcotics, which are systemic and pose a risk of addiction, you could just put that piece of the body to sleep, so to speak.”

Previous attempts to develop slow-release anesthetics have not been successful because of the tendency for conventional anesthetics to cause toxicity to surrounding tissue. Indeed, drug-packaging materials have themselves been shown to cause tissue damage. Now, Kohane and colleagues report that if saxitoxin is packaged within liposomes, it is able to block nerve transmission of pain without causing significant nerve or muscle damage.

In lab experiments, the researchers evaluated various formulations - various types of liposomes containing saxitoxin with or without dexamethasone, a potent steroid known to augment the action of encapsulated anesthetics. The best liposomes produced nerve blocks lasting two days if they contained saxitoxin alone and seven days if combined with dexamethasone.

Cell culture experiments and tissue analysis confirmed that the formulations were not toxic to muscle or nerve cells. Furthermore, when the team examined expression of four genes known to be associated with nerve injury, they found no up-regulation.

“If these long-acting, low-toxicity formulations of local anesthetics are shown to be effective in humans, they could have a major impact on the treatment of acute and ,” says Alison Cole of the NIH’s National Institute of General Medical Sciences, which partially funded the work. “This slow-release technology may also have broader applications in drug delivery for the treatment of a variety of diseases.”

Kohane is currently optimizing the formulation to make it last even longer, while avoiding local and systemic toxicity. “It is conceivable we could have a formulation that is suitable for clinical trials before too long,” he says.

Hila Epstein-Barash, a research fellow in anesthesia at Children’s Hospital, was first author on the paper.

Provided by Harvard University (news : web)

Explore further: Stem cells faulty in Duchenne muscular dystrophy

add to favorites email to friend print save as pdf

Related Stories

Treatment blocks pain without disrupting other functions

Oct 03, 2007

A combination of two drugs can selectively block pain-sensing neurons in rats without impairing movement or other sensations such as touch, according to a new study by National Institutes of Health (NIH)-supported investigators. ...

Probing Question: How does anesthesia work?

Oct 25, 2007

Many inventions of the 19th century -- telephones, airplanes, phonographs -- have helped to shape the modern world. However, it could be argued that the 1846 discovery of effective surgical anesthesia holds a place of honor ...

Protein found that may provide relief from neuropathic pain

Dec 05, 2007

Neuropathic pain is caused by injury to the peripheral nerves in diseases such as HIV/AIDS, shingles, and cancer or in repetitive motion disorders and trauma, and does not respond well to conventional pain-relieving drugs.

Chili pepper cocktail points to wide-awake surgery

Oct 04, 2007

Imagine an epidural or a shot of Novocain that doesn’t paralyze your legs or make you numb yet totally blocks your pain. This type of pain management is now within reach. As a result, childbirth, surgery, ...

Recommended for you

Stem cells faulty in Duchenne muscular dystrophy

12 hours ago

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have ...

Here's how the prion protein protects us

17 hours ago

The cellular prion protein (PrPC) has the ability to protect the brain's neurons. Although scientists have known about this protective physiological function for some time, they were lacking detailed knowledge ...

Regulation of maternal miRNAs in early embryos revealed

18 hours ago

The Center for RNA Research at the Institute for Basic Science (IBS) has succeeded in revealing, for the first time, the mechanism of how miRNAs, which control gene expression, are regulated in the early embryonic stage.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.